The following leaders of Southern Africa’s Infectious Diseases
Community are hereby acknowledged as honorary life members of the
Federation of Infectious Diseases Societies of Southern Africa. They
share the common characteristic of having made outstanding
contributions to South African Medicine in the field of Infectious
Diseases, Clinical Microbiology and Infection Control, and to FIDSSA
itself.
Professor Lucille Blumberg is a deputy director at
the National Institute for Communicable Diseases, a branch of the
National Health Laboratory Service, and is based in Johannesburg,
South Africa. She heads the Epidemiology Division, which includes
the units for Outbreak Response, Travel and International Health,
Epidemiology and Surveillance, as well as the Field Epidemiology and
Laboratory Training programme. She is the medical consultant to the
Special Pathogens Unit on rabies and Viral Haemorrhagic fevers. She
is an Associate Professor at the University of the Stellenbosch,
Western Cape Province. Prof Blumberg is a nationally and
internationally renowned Infectious Diseases specialist, clinical
microbiologist and travel medicine specialist. Her special interests
are tropical and travel-related diseases, zoonosis, drug-resistant
TB and management of severe malaria. She is a member of a number of
South African and international expert groups and has been involved
in a number of outbreaks in South Africa including cholera, rabies,
Rift Valley fever, Lujo virus and influenza A H5N1.
FIDSSA tribute: Lucille is past President of the
Infectious Diseases Society of Southern Africa and is its current
treasurer. She is also the ex-officio secretary/treasurer of FIDSSA
and continues to work tirelessly as a member of the FIDSSA council
and its executive committee. Lucille has an indomitable spirit, and
is a much-loved teacher, mentor and colleague to many generations of
South African health practitioners, spanning human and veterinary
medicine.
Dr Adrian Brink gained his MB BCh degree from the
University of Pretoria in South Africa in 1984, before completing
further medical training including his M Med (Clinical Microbiology)
degree, in 1994. He currently works in Johannesburg, South Africa,
as a Clinical Microbiologist, Ampath National Laboratory Services,
Milpark Hospital, Johannesburg. His research interests include
antibiotic resistance in intensive-care-related infections, and the
pharmacokinetics and outcome measures of antibiotics in
healthcare-associated infections.
FIDSSA tribute: Adrian is an internationally
acclaimed microbiologist, and a much sort-after speaker at
international meetings. Adrian was Chairman of the National
Antibiotic Surveillance Forum (NASF) and is the ex-officio President
of FIDSSA, having become its first president in 2005. Adrian’s drive
and vision put FIDSSA firmly on the map and his continued
contributions to FIDSSA have been outstanding. He is the driving
force behind the highly successful InspiRaTIon meetings in
association with Aspen Pharmacare, which provide continuing
professional development to practitioners emphasizing the
microbiology and management of respiratory tract infections in
adults and children. Adrian has shunned many offers as a handbag
model for Louis Vuitton, rather choosing to enjoy travelling the
world as one of life’s bon viveurs.
Professor Charles Feldman was born and brought up
in Johannesburg, South Africa. He obtained his MB BCh degree at the
University of the Witwatersrand, in Johannesburg, in 1975 and served
his internship at Johannesburg Hospital. He subsequently did his
fellowship training in Internal Medicine at Johannesburg Hospital
and received his FCP (SA) in 1981. He received his PhD in 1991 for a
thesis entitled “Aspects of Community-acquired Pneumonia” and his
DSc in 2009 for a thesis entitled “Contributions to an Understanding
of Community-acquired Pneumonia”. He was registered as a
sub-specialist in Pulmonology in 1993 and was elected to the
Fellowship of the Royal College of Physicians (FRCP) in 1997. In
1988/89 he was a Research Fellow and Honorary Senior Visiting
Colleague, in the Host Defence Unit, Department of Thoracic
Medicine, National Heart and Lung Institute, and Royal Brompton
Hospital, London, United Kingdom. In May 1995 he was appointed as
Professor of Pulmonology and Chief Physician, at Johannesburg
Hospital and the University of the Witwatersrand, a position, which
he currently holds. He is a member of a number of national and
international societies, including the American Thoracic Society
(ATS), the American College of Chest Physicians (ACCP), the European
Respiratory Society and the British Thoracic Society. He is active
in the ATS Conference Scientific Program Committee for the MTPI
Assembly and is currently the South African representative on the
European Respiratory Society. He has been President of the South
African Thoracic Society on 2 previous occasions. Professor
Feldman’s research interest is in the field of community-acquired
pneumonia, and in particular pneumococcal pneumonia. In addition to
being part of large international clinical collaborations recruiting
cases of community-acquired pneumonia he has also contributed to
basic research studies, investigating the effects of various
pneumococcal virulence factors on human ciliated epithelium as well
as the effects of antibiotics on pneumococcal growth and expression
of virulence factors. He has more than 300 publications in books,
book chapters, and in both indexed and DE accredited peer reviewed
journals.
FIDSSA tribute: Charles is the Editor-in-Chief of
FIDSSA’s journal The Southern African Journal of Epidemiology and
Infection, having taken over from Professor Hendrik Koornhof.
Charles has worked tirelessly to develop and improve the journal
which is FIDSSA’s flagship, and he is recognized for his outstanding
contribution to the society in this regard, as well as the many
accolades for which he is known both nationally and on the
international stage, that are detailed above.
Professor Hendrik Koornhof graduated in 1951 at the
University of Cape Town and obtained the Diploma at Clinical
Pathology at the Royal Postgraduate School of Pathology,
Hammersmith, London in 1960, the Diploma in Bacteriology at the
London School of Hygiene and Tropical Medicine, in 1966 and became a
Founder Member of the Royal College of Pathology, London in 1973. He
was awarded an Honorary DSc degree by the University of the
Witwatersrand in 1997 and was elected Fellow of the American Academy
of Microbiology in 2009. During his career as medical microbiologist
from 1960 to 1991, he was Head of Medical Microbiology at the South
African Institute for Medical Research for 31 years, and since 1971,
with the establishment of the School of Pathology, he became
Professor and Head of the Department of Pathology (Microbiological)
(later renamed Department of Medical Microbiology) for twenty years.
After his retirement in 1991 he was awarded Emeritus Professor and
Honorary Professorial Research Fellow status by the University of
the Witwatersrand and in that capacity was Acting Head of the
Department of Clinical Microbiology from 1995 to 1998, Acting Head,
Sexually Transmitted Infections Reference Centre (STIRC) from 2002
to 2004, Coordinator, Microbiology External Quality Assessment
Programme of the National Health Laboratory Service (NHLS) from 2007
to 2010 and research advisor to the Epidemiology Division of the
National Institute for Communicable Diseases (NICD) from 2005 and
the National Tuberculosis Reference Laboratory NHLS since 2006.
Regarding his research activities, he was Director of the MRC
Emergent Pathogen Research Unit from 1981 to 1992 and his research
activities covered a wide range of bacterial pathogens, including
salmonellae, Yersinia enterocolitica, Campylobacter jejuni,
Legionella pneumophila and multidrug-resistant Streptococcus
pneumoniae and more recently Mycobacterium tuberculosis. He was a
senior collaborator in evaluation studies of bacterial vaccines in
South Africa, including several polyvalent pneumococcal
polysaccharide vaccine formulations in gold miners in the 1970s
initiated by Professor Robert Austrian, and under the direction of
Professor Keith Klugman a 9-valent pneumococcal conjugate vaccine in
children with and without HIV infection in 2003 and the earlier
evaluation of the Salmonella typhi Vi capsular polysaccharide in
rural school-aged children. Professor Koornhof received the gold
medal from the South African Society for Microbiology in 1992 for
outstanding services to microbiology in South Africa over an
extended period.
FIDSSA tribute: Prof Koornhof is one of the true
giants of South African Medicine as exemplified in his many
achievements outlined above. He was made an honorary life member of
FIDSSA in recognition of these contributions and his development of
and ongoing contribution to the running of FIDSSA’s journal, the
Southern African Journal of Epidemiology and Infection (SAJEI), as
Editor-in-Chief before Charles Feldman.
Dr Steve Oliver worked in Medical Microbiology at
Groote Schuur Hospital (GSH) for 35 years. His career started with
the first appearance of MRSA at GSH, which sparked an interest in
Infection Control that remained with him throughout. He was involved
in the initial formation of a National Infection Control Society and
the first congresses organized under the umbrella of that body. His
interest in antibiotic stewardship resulted in the printing of a
Groote Schuur Antibiotic Recommendations booklet compiled in
consultation with colleagues in Microbiology and Infectious
Diseases, that has gone on to be an annual publication distributed
widely in the Western Cape. Teaching, both under- and postgraduate,
has also been an abiding interest and medical students at UCT
nominated him for a distinguished teacher award. He embraced the
introduction of the new curriculum for undergraduate teaching
enthusiastically and was responsible for microbiology teaching in
this new venture.
FIDSSA tribute: Steve Oliver has made an
outstanding contribution to Medical Microbiology in South Africa,
both as a practitioner, and as a teacher and mentor. He has been a
tireless supporter of Infection Control, Microbiology Infectious
Diseases and numerous societies including FIDSSA throughout his
career. His quiet, calm and professional approach has won him
innumerable friends and admirers throughout his career and his
retirement will leave the South African Microbiology, Infection
Control and Infectious Diseases community much the poorer.
Professor Barry Schoub was born in Johannesburg and
received his undergraduate MB BCh at the University of
Witwatersrand, followed by an MD and DSc. He is a Fellow of the
College of Pathology of South Africa, Fellow of the Royal College of
Pathology, a Fellow of the Royal Society of South Africa and an
elected member of the Academy of Science of South Africa. He was
appointed as the first Professor and Head of the Department of
Virology of the University of the Witwatersrand in 1978 at the age
of 33 and in 1982 became the Director of the National Institute for
Virology. In January 2002 Professor Schoub was appointed as the
Executive Director of the newly established National Institute for
Communicable Diseases, a post he has held until his retirement at
the end of August 2010. In 1977 he received a United States Public
Health Service international postdoctoral fellowship and was the
first recipient of the James Gear International Postdoctoral
Fellowship and was a Fogarty fellow at the National Institutes of
Health in Bethesda, USA, until the latter part of 1978. Barry has
been a member of a number of international bodies and has served as
an advisor for several WHO programmes including polio, measles, RSV
and influenza. He was a member of the Advisory Committee for
Poliomyelitis Eradication [ACPE] of the World Health Organization.
He was a member of the Board of the International Association of
Public Health Institutes (IANPHI) and has served on the Task Force
for Immunization for WHO (AFRO). Barry was a member of the interim
board of the International Society of Influenza and Respiratory
Viruses and served as South Africa’s delegate to the International
Union of Microbiological Societies. He was the founding Chairman and
current member of the National Advisory Group on Immunization of
South Africa and was the founding President of the African Virology
Association. He is the chairman of the Scientific Advisory Panel and
vice-chairmen of the Board of Trustees of the Poliomyelitis Research
Foundation He served on the Scientific Advisory Committee of the
South African AIDS Vaccine initiative. He was on the International
Scientific Advisory Committees of the 1990, 1996 and 1999
International Congresses of Virology and the 1996 and 1998
International AIDS Congresses He has published over 270 scientific
publications, 16 chapters in books and has written a book on
HIV/AIDS, entitled “AIDS & HIV in Perspective”, published by
Cambridge University Press now in its 2nd edition. Amongst the
awards he has received are the Paul Harris Award of Rotary
International and the Daubenton prize of the University of the
Witwatersrand.
FIDSSA tribute: Throughout his illustrious career,
Barry Schoub has quietly gone about making an immense contribution
to the medicine and science of virology and infectious diseases in
its broadest sense. He led the NICD from its inception and helped
build it into the force it now is in South Africa and the African
continent. His thoughtfulness, dedication and humble approach to the
many tasks that he has been set is an example to us all. He has made
multiple invaluable contributions to FIDSSA and its individual
societies over the years.
International Honorary Life Members of FIDSSA
The following internationally renowned specialists have
been made honorary life members of FIDSSA:
Professor Nicholas White is Professor of Tropical
Medicine at the Faculty of Tropical Medicine Mahidol University and
Oxford University, and is also a Consultant Physician at the John
Radcliffe Hospital, Oxford, UK. He has lived in Thailand and worked
in the Faculty of Tropical Medicine, Mahidol University since 1980.
Professor White chairs the Wellcome Trust Tropical Medicine Research
Programme in South-East Asia, and the Oxford Tropical Medicine
Network (encompassing research groups in Thailand, Vietnam, Laos,
Kenya and the Gambia). He also currently co-chairs the World Health
Organization anti-malarial treatment guidelines committee and the
WHO Global Malaria Programme case management cluster. His principal
research interests are malaria, particularly the pathophysiology and
treatment of malaria, and also other severe tropical infectious
diseases (melioidosis, typhoid, pyogenic, tuberculosis and fungal
meningitis, dengue, viral encephalitis, pneumococcal infections,
diphtheria and tetanus). His is currently on the editorial boards of
11 scientific journals including The Lancet, PLOS Medicine, the
European Journal of Clinical Pharmacology and Antimicrobial Agents
and Chemotherapy. He has published over 760 scientific papers and
over 39 book chapters.
FIDSSA tribute: Nick has been a wonderful friend to
FIDSSA since its inception, and has spoken at each conference since
2007. Nick’s enormous experience and leadership in the field of
malaria and so many other serious tropical infectious diseases
shines out in his plenaries and talks at parallel sessions. He is
always willing to roll up his sleeves and get involved, and we have
been extremely fortunate that he has been willing to return again
and again.
Dr David Livermore gained his BSc at Heriot-Watt
University in Edinburgh in 1978 and his PhD from the University of
London in 1983. He worked at the London Hospital Medical College
form 1980 until 1997, then moving to the Central Public Health
Laboratory (CPHL), which became part of the Health Protection Agency
in 2003. He is now Director of the Agency’s Antibiotic Resistance
Monitoring and Reference Laboratory (ARMRL), where he has
responsibility for investigating bacteria with unusual resistance
phenotypes and assessing their mechanisms and public health
importance. Dr Livermore serves or ahs served on various editorial
boards and scientific committees, including, from 2001-7, the UK
Government’s Specialist Advisory Committee on Antibiotic Resistance.
He has published over 300 papers on antibiotics and resistance in
peer-reviewed journals.
FIDSSA tribute: Like Nick White, David Livermore
has been a wonderful friend to FIDSSA and has been involved in many
of our conferences. His unique lecturing style has audiences
captivated and his excellence in teaching and getting to the heart
of the issue makes him an in-demand international speaker. We look
forward to welcoming David back to South Africa in the future.
| Website terms of use | Privacy Policy | Admin | Powered by | ![]() |